Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05398640
Title Expanded Access Program of Lifileucel (LN-144) in Patients With Unresectable or Metastatic Melanoma
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Iovance Biotherapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Orlando Health Cancer Institute AVAILABLE Orlando Florida 32806 United States Details
Northside Hospital AVAILABLE Atlanta Georgia 30342 United States Details
The University of Kansas Cancer Center AVAILABLE Westwood Kansas 66205 United States Details
University of Louisville - James Graham Brown Cancer Center AVAILABLE Louisville Kentucky 40202 United States Details
Massachusetts General Hospital AVAILABLE Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute AVAILABLE Boston Massachusetts 02215 United States Details
Washington University - Barnes Jewish Hospital AVAILABLE Saint Louis Missouri 63110 United States Details
MD Anderson Cancer Center at Cooper AVAILABLE Camden New Jersey 08103 United States Details
Memorial Sloan Kettering Cancer Center AVAILABLE New York New York 10065 United States Details
St. Lukes Hospital AVAILABLE Bethlehem Pennsylvania 18015-1000 United States Details
Avera Cancer Institute AVAILABLE Sioux Falls South Dakota 57105 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field